And I have another story on this:

Even while waiting for data to roll in, both providers and payers agree that AI scribes are driving up the cost of care in the middle of an affordability crisis.

What, if anything, are we going to do about it?

#health #healthcare #medicine #AI #artificialintelligence #healthtech #AIscribe #ambientscribe #healthcarecosts

https://www.statnews.com/2026/04/08/insurers-providers-agree-ai-scribes-raise-health-care-costs/

Everyone agrees AI scribes are increasing health care costs. No one agrees what to do about it

Behind closed doors, health insurers and hospitals agree that AI scribes are bumping up health care costs. But, they don't agree on a solution.

STAT

Coding intensity for patient visits is rising. Did AI scribes do that?

You may have seen the Trilliant study that alleges AI scribes are making visit coding go up. But what does the study actually say?

An analysis of that, and much more, in this week's AI Prognosis:

https://www.statnews.com/2026/04/08/are-scribes-raising-health-care-costs-ai-prognosis/

#health #healthcare #medicine #AI #artificialintelligence #healthtech #AIscribe #ambientscribe #healthcarecosts

RE: https://newsie.social/@STAT/116369440554418902

"A decade ago, these drugs tore apart the FDA. Today, they might be some patients’ best hope

Once-divisive ‘exon-skipping’ treatments for Duchenne muscular dystrophy are showing startling promise"

By Jason Mast
April 8, 2026

LinkedIn past tracker wall:

https://archive.ph/V9f6f

#Netherlands #Dutch #medicalResearch #medicine

Less than 20% of people in Japan who showed interest in new medications for Alzheimer's disease went on to receive one, mainly because they were not medically eligible or they decided against it for fear of side effects. https://www.japantimes.co.jp/news/2026/04/08/japan/science-health/dementia-drugs-research/?utm_medium=Social&utm_source=mastodon #japan #sciencehealth #alzheimers #lecanemab #donanemab #health #medicine #dementia #brain
Less than 20% of patients in Japan interested in new Alzheimer’s drugs received one

Many were ineligible or decided against taking the medications due to potential side effects and the high cost, a study has found.

The Japan Times
Real Medicine focuses on restoring normal physiology.
#medicine #health

#Futures: #humanities #psychiatry #politics #medicine

Achille Mbembe speaks on Frantz Fanon 📍 When the #clinical and the #political are co-constitutive

Achille Mbembe, political theorist and philosopher, speaks on the 20th century Caribbean psychiatrist Frantz #Fanon (Martinique). Franklin Humanities Institute (FHI) at Duke University. Mbembe is the 2024 Holberg Prize Laureate.

📍 https://www.youtube.com/watch?v=lg_BEodNaEA

Achille Mbembe - Frantz Fanon and the Politics of Viscerality

YouTube
How Kidney Stones Form

PeerTube

Nature: Scientists invented a fake disease. AI told people it was real. “The problem was that the experiment worked too well. Within weeks of her uploading information about the condition, attributed to a fictional author, major artificial-intelligence systems began repeating the invented condition as if it were real. Even more troublingly, other researchers say, the fake papers were then cited […]

https://rbfirehose.com/2026/04/08/nature-scientists-invented-a-fake-disease-ai-told-people-it-was-real/
Nature: Scientists invented a fake disease. AI told people it was real

Nature: Scientists invented a fake disease. AI told people it was real. “The problem was that the experiment worked too well. Within weeks of her uploading information about the condition, at…

ResearchBuzz: Firehose
Scientists Have Found a New Neurodevelopmental Disorder Hidden in Our Genes

Researchers have identified a previously unknown neurodevelopmental disorder influenced by genetics – a discovery that promises new diagnoses for thousands of children and families worldwide.

ScienceAlert